Amir Avniel
President chez BEYOND AIR, INC.
Fortune : 514 682 $ au 30/04/2024
Provenance du réseau au premier degré de Amir Avniel
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Medical Specialties | 33 | |
Beyond Air Ltd.
 Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel.
24
| Subsidiary | Biotechnology | 24 |
| Public Company | Biotechnology | 13 | |
| Public Company | Financial Conglomerates | 8 | |
Beyond Cancer, Ltd.
 Beyond Cancer, Ltd. BiotechnologyHealth Technology Beyond Cancer, Ltd. is a development-stage biopharmaceutical and Bermudian medical device company that utilizes a proprietary delivery platform to treat primary tumors and prevent metastatic disease. The private company is based in Hamilton, Bermuda. Beyond Cancer is currently conducting a first-in-human study in patients with solid tumors and is focused on next level immuno-oncology. The CEO of the company is Selena A. Chaisson.
6
| Private Company | Biotechnology | 6 |
Ait Ltd.
 Ait Ltd. BiotechnologyHealth Technology Ait Ltd. engages in research and development in biotechnology. The private company is located in Israel. The Israeli company was founded by Yossef Av-Gay, Amir Avniel, Avishai Abrahami. Amir Avniel has been the CEO of the company since 2011.
3
| Private Company | Biotechnology | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Amir Avniel via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| GT BIOPHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| PFIZER, INC. | Pharmaceuticals: Major | Public Communications Contact | |
| SUNY CELLULAR COMMUNICATION LTD | Electronics Distributors | Chief Executive Officer Director/Board Member | |
| RADVIEW SOFTWARE LTD. | Packaged Software | Director of Finance/CFO | |
Gammacan International, Inc.
 Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Medical Specialties | Director of Finance/CFO | |
| PLURI INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Warwick Business School | College/University | Masters Business Admin | |
| ABRA INFORMATION TECHNOLOGIES LTD. | Packaged Software | Comptroller/Controller/Auditor Director of Finance/CFO | |
Enox Biopharma, Inc.
 Enox Biopharma, Inc. Medical SpecialtiesHealth Technology Enox Biopharma, Inc. operated in the development of Develops antimicrobial medical devices coated with Nitric Oxide. It products include urinary catheters, endotracheal tubes, central venous lines and other short term indwelling devices. The company was founded by Yossef Av-Gay on June 27, 2007 and is headquartered in Yehud-Monosson, Israel. | Medical Specialties | Founder Chief Tech/Sci/R&D Officer | |
| BIOSIG TECHNOLOGIES, INC. | Medical Specialties | Director/Board Member | |
| NEXIMMUNE, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Investor Relations Contact | |
| XTL BIOPHARMACEUTICALS LTD. | Medical Specialties | Chief Executive Officer Chief Executive Officer | |
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Kost Forer Gabbay & Kasierer
 Kost Forer Gabbay & Kasierer Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Kost Forer Gabbay & Kasierer is an Israeli company that offers audit, FAAS, and forensic & integrity services to address risk and identify opportunities to enhance trust in the capital markets. The private company is based in Tel Aviv, Israel. The company also has EY-Parthenon teams that help CEOs create long-term value from strategy to execution. Additionally, Kost Forer Gabbay & Kasierer's analytics consulting services utilize the latest technology to integrate data and analytics throughout business processes and operations. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Corporate Officer/Principal | |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| GIX INTERNET LTD | Publishing: Newspapers | Chairman Corporate Officer/Principal | |
| University of British Columbia | College/University | Corporate Officer/Principal Doctorate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Undergraduate Degree Masters Business Admin Doctorate Degree Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree Doctorate Degree | |
| Technion-Israel Institute of Technology | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Undergraduate Degree | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Bar-Ilan University | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
Ernst & Young (Israel) Ltd.
 Ernst & Young (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young (Israel) Ltd. is an Israeli company that provides accounting services. The private company is based in Tel Aviv, Israel. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| BARAK INVESTMENT HOUSE LTD | Real Estate Development | Director/Board Member | |
| Cohen, Cohen, Yaron-Eldar & Co. | Corporate Officer/Principal | ||
Parkway Clinical Laboratories, Inc.
 Parkway Clinical Laboratories, Inc. Medical/Nursing ServicesHealth Services Parkway Clinical Laboratories, Inc. operates a clinical reference laboratory that performs routine and esoteric diagnostic testing services. The firm provides addiction management, body fluid testing, integrative diagnostic, pain management, opioid prescription monitoring, and workforce screening services. It also supports anti-aging and wellness providers in the initial diagnosis and ongoing care of patients suffering from chronic diseases, nutritional deficiencies, and cardiovascular risks. The company is headquartered in Bensalem, PA. | Medical/Nursing Services | Chairman Chief Tech/Sci/R&D Officer | |
| Weill Cornell Medical College | College/University | Corporate Officer/Principal | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Immodulon Therapeutics Ltd.
 Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Part of Lifexx SA, Immodulon Therapeutics Ltd. is a late-stage clinical biotechnology company based in Uxbridge, UK. Immodulon is developing a highly differentiated cancer immunotherapy approach that primes the patient’s own innate immune system with the aim to significantly enhance the efficacy of a broad range of anti-cancer therapies, including chemotherapy and checkpoint inhibitors. The British company is developing imm-101, a heat-killed mycobacterium obuense, as a broad-spectrum immunomodulatory agent with the potential to treat a range of difficult-to-treat tumors including those considered to be immunologically “ cold, ” such as pancreatic cancer. Immodulon's imm-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. The private company is focused on developing safe and effective immunotherapy treatments. The company was founded in 2007 by Charles Akle, John L. Stanford. Gertjan Bartlema has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
| The College of Management Academic Studies | College/University | Masters Business Admin Undergraduate Degree | |
| NEXGEL, INC. | Chemicals: Specialty | Director/Board Member | |
| NEXTGEN BIOMED LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Ruppin Academic Institute | College/University | Chairman Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
| New York University School of Law | College/University | Doctorate Degree Graduate Degree | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
Zimmer US, Inc.
 Zimmer US, Inc. Medical SpecialtiesHealth Technology Zimmer US, Inc. manufactures and distributes orthopedic reconstructive implants. The company was founded in 1927 and is headquartered in Warsaw, IN. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
| REE AUTOMOTIVE LTD. | Auto Parts: OEM | Director/Board Member Director of Finance/CFO | |
| CLARITAS PHARMACEUTICALS, INC. | Pharmaceuticals: Other | Director/Board Member | |
| Celgene Global Health | Chief Executive Officer | ||
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Biond Biologics Ltd.
 Biond Biologics Ltd. Pharmaceuticals: MajorHealth Technology Biond Biologics Ltd. engages in drug discovery and development. It offers cell-internalizing antibody platform that will enable antibody-targeting of intra-cellular immune factors. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| Arthritis Foundation New Jersey Chapter | Director/Board Member | ||
Viralclear Pharmaceuticals, Inc.
 Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ViralClear Pharmaceuticals, Inc. manufactures anti-viral drug. The company is headquartered in Westport, CT. | Pharmaceuticals: Major | Chairman |
Statistiques
Internationale
| Etats-Unis | 24 |
| Israël | 24 |
| Royaume-Uni | 3 |
| Suisse | 2 |
| Canada | 2 |
Sectorielle
| Health Technology | 23 |
| Consumer Services | 13 |
| Commercial Services | 4 |
| Technology Services | 3 |
| Finance | 3 |
Opérationnelle
| Director/Board Member | 232 |
| Corporate Officer/Principal | 119 |
| Director of Finance/CFO | 56 |
| Independent Dir/Board Member | 56 |
| Chairman | 49 |
Relations les plus connectées
| Insiders | |
|---|---|
| Jerome Zeldis | 38 |
| Joshua Rosensweig | 36 |
| Yoav Z. Chelouche | 35 |
| Tal Yaron Eldar | 33 |
| Stephen DiPalma | 24 |
| Robert Carey | 23 |
| David Grossman | 22 |
| Erick Lucera | 18 |
| Gregory Berk | 17 |
| Raza Bokhari | 16 |
| Steven Lisi | 16 |
| Homi Shamir | 16 |
| Aviad Friedman | 14 |
| Ari Raved | 14 |
| Douglas Beck | 14 |
- Bourse
- Insiders
- Amir Avniel
- Connexions Sociétés
